Author

K. Fitzgerald

Listed by name: these papers carry no ORCID for this author, so different people with the same name may be mixed together.

Biology Disciplines

Click to filter author papers

Cancer Biology· 2 Biophysics· 1 Cell Biology· 1 Pharmacology & Toxicology· 1

Signature Assays, Organisms & Methods

Click to filter · or open tag

Approach:experimental assay· 4 Assay:bulk RNA-seq· 2 Research Focus:cancer & tumor microenvironment· 2 Organism:human· 2 Organism:mouse· 2 Research Focus:cell type annotation· 1 Research Focus:development & morphogenesis· 1 Research Focus:differential expression· 1

Frequent Co-Authors

A. A. Hakimi· 1 shared A. Akinc· 1 shared A. B. Castoreno· 1 shared A. J. Gill· 1 shared A. Kasper· 1 shared A. N. Consiglio· 1 shared A. Rogers· 1 shared A. Sahakyan· 1 shared

Activity by Year

2019-2023 · peak 1/yr

Co-Author Collaboration Network

10 top collaborators · 18 mutual co-author links

Click any collaborator node to inspect or filter shared papers

Focal author (center)Selected co-authorORCID co-authorUnlinked name

Curved chords = mutual co-authorship

1 shared paperCancer Biology

A. A. Hakimi

Mutual co-authors in cluster

Author profile →

5 papers

Recent·Most cited

Cryopreservation and revival of Hawaiian stony corals via isochoric vitrification

M. J. Powell-Palm, E. M. Henley, A. N. Consiglio, C. Lager, B. Chang, R. Perry, K. Fitzgerald, J. Daly, B. Rubinsky, M. Hagedorn

This paper reports the first successful cryopreservation and revival of Hawaiian stony coral fragments using isochoric vitrification, demonstrating viability and a prototype pipeline for global coral conservation.

bioRxiv · Mar 5, 2023Biophysics

Robust and durable prophylactic protection conferred by RNA interference in preclinical models of SARS-CoV-2

Y. I. Anglero-Rodriguez, F. A. Lempp, J. McIninch, M. K. Schlegel, C. R. Brown, D. J. Foster, A. B. Castoreno, T. Nguyen, M. Subramanian, M. Montiel-Ruiz, H. Kaiser, A. Sahakyan, R. Spreafico, S. S. Morskaya, J. D. Barry, , V. Jadhav

This study identifies two siRNA combinations that provide robust prophylactic protection against SARS-CoV-2 in hamsters by reducing viral load and preventing lung pathology.

bioRxiv · Mar 20, 2022 · PreprintPharmacology & Toxicology

Genomic and Metabolic Hallmarks of SDH- and FH-Deficient Renal Cell Carcinomas

A. Yoo, C. Tang, M. Zucker, K. Fitzgerald, P. M. Rappold, K. Weiss, B. Freeman, C.-H. Lee, N. Schultz, R. Motzer, P. Russo, J. Coleman, V. E. Reuter, Y.-B. Chen, M. I. Carlo, , E. Reznik

This study compares the genomic and metabolic features of SDH- and FH-deficient renal cell carcinomas, identifying distinct genetic and metabolic abnormalities.

bioRxiv · Jun 9, 2021Cancer Biology

Targeting the oncogene LSF with either the small molecule inhibitor FQI1 or siRNA causes mitotic delays with unaligned chromosomes, resulting in cell death or senescence

J. L. S. Willoughby, K. George, M. P. Roberto, H. G. Chin, P. Stoiber, H. Shin, C. S. Pedamallu, S. E. Schaus, K. Fitzgerald, J. Shah, U. Hansen

This study shows that inhibiting LSF with FQI1 or siRNA causes mitotic delays and cell death in HeLa cells, supporting LSF as a cancer therapeutic target.

bioRxiv · Jan 26, 2020Cancer Biology

Pericyte Bridges in Homeostasis and Hyperglycemia: Reconsidering Pericyte Dropout and Microvascular Structures

B. A. Corliss, H. C. Ray, R. Doty, C. Mathews, N. Sheybani, K. Fitzgerald, R. Prince, M. Kelly-Goss, W. L. Murfee, J. Chappell, G. Owens, P. A. Yates, S. M. Peirce

The paper reevaluates pericyte dropout in diabetic retinopathy, showing pericyte bridges are misclassified and highlighting their role in disease progression.

bioRxiv · Jul 16, 2019 · PreprintCell Biology